| MESOBLAST LTD. |
| Australien |
| Gesundheit |
| AU000000MSB8 / A0DNPW |
| LWB (Frankfurt) |
| FRA:LWB, ETR:LWB, LWB:GR |
| - |
| https://www.mesoblast.com.. |
|
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory conditions. Leveraging a proprietary technology pl..
>Volltext.. |
| 1445.69 Mio. EUR |
| 1467.07 Mio. EUR |
| 108.96 Mio. EUR |
| -39.21 Mio. EUR |
| -53.09 Mio. EUR |
| -0.04 EUR |
| 113.5 Mio. EUR |
| 91.73 Mio. EUR |
| -58.84 Mio. EUR |
| 1.27 |
| 611.48% |
| 40.94% |
| - |
| - |
| - |
| - |
| MESOBLAST |
| 25.10.26 |
|